Silence superoxide dismutase 1 (SOD1): a promising therapeutic target for amyotrophic lateral sclerosis (ALS)

E Abati, N Bresolin, G Comi, S Corti - Expert opinion on therapeutic …, 2020 - Taylor & Francis
Introduction: Amyotrophic lateral sclerosis (ALS) is a progressive and incurable
neurodegenerative disorder that targets upper and lower motor neurons and leads to fatal …

Silencing strategies for therapy of SOD1-mediated ALS

B van Zundert, RH Brown Jr - Neuroscience Letters, 2017 - Elsevier
Amyotrophic lateral sclerosis (ALS) is an adult-onset, lethal, paralytic disorder caused by the
degeneration of motor neurons. Our understanding of this disease has been greatly …

SOD1 silencing in motoneurons or glia rescues neuromuscular function in ALS mice

E Dirren, J Aebischer, C Rochat… - Annals of clinical …, 2015 - Wiley Online Library
Objective Amyotrophic lateral sclerosis is an incurable disorder mainly characterized by
motoneuron degeneration. Mutations in the superoxide dismutase 1 (SOD 1) gene account …

[HTML][HTML] Translating SOD1 gene silencing toward the clinic: a highly efficacious, off-target-free, and biomarker-supported strategy for fALS

T Iannitti, JM Scarrott, S Likhite, IRP Coldicott… - … Therapy-Nucleic Acids, 2018 - cell.com
Of familial amyotrophic lateral sclerosis (fALS) cases, 20% are caused by mutations in the
gene encoding human cytosolic Cu/Zn superoxide dismutase (hSOD1). Efficient translation …

Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques

F Borel, G Gernoux, H Sun, R Stock… - Science Translational …, 2018 - science.org
Amyotrophic lateral sclerosis (ALS) is a fatal neurological disease caused by degeneration
of motor neurons leading to rapidly progressive paralysis. About 10% of cases are caused …

Perspective on SOD1 mediated toxicity in Amyotrophic Lateral Sclerosis

S Sangwan, DS Eisenberg - Postępy Biochemii, 2016 - postepybiochemii.ptbioch.edu.pl
A myotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by
the progressive degeneration of spinal motor neurons. Although mutations in dozens of …

A new zebrafish model produced by TILLING of SOD1-related amyotrophic lateral sclerosis replicates key features of the disease and represents a tool for in vivo …

MMJ Da Costa, CE Allen… - Disease models & …, 2014 - journals.biologists.com
Mutations in the superoxide dismutase gene (SOD1) are one cause of familial amyotrophic
lateral sclerosis [ALS; also known as motor neuron disease (MND)] in humans. ALS is a …

RNA interference-mediated silencing of mutant superoxide dismutase rescues cyclosporin A-induced death in cultured neuroblastoma cells

MM Maxwell, P Pasinelli… - Proceedings of the …, 2004 - National Acad Sciences
Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disorder
resulting from selective death of motor neurons in the brain and spinal cord. In≈ 25% of …

Amyotrophic lateral sclerosis associated with mutations in superoxide dismutase: a putative mechanism of degeneration

BM Morrison, JH Morrison - Brain research reviews, 1999 - Elsevier
Amyotrophic lateral sclerosis (ALS) is a devastating neurologic disease that rapidly
progresses from mild motor symptoms to severe motor paralysis and premature death. Until …

Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model

GS Ralph, PA Radcliffe, DM Day, JM Carthy… - Nature medicine, 2005 - nature.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease resulting in the
selective death of motor neurons in the brain and spinal cord. Some familial cases of ALS …